Cargando…
No Evidence for Mutations of CTCFL/BORIS in Silver-Russell Syndrome Patients with IGF2/H19 Imprinting Control Region 1 Hypomethylation
BACKGROUND: Silver-Russell syndrome (SRS) is a genetically and clinically heterogeneous disease. Although no protein coding gene defects have been reported in SRS patients, approximately 50% of SRS patients carry epimutations (hypomethylation) at the IGF2/H19 imprinting control region 1 (ICR1). Prop...
Autores principales: | Bernier-Latmani, Jeremiah, Baumer, Alessandra, Shaw, Phillip |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721151/ https://www.ncbi.nlm.nih.gov/pubmed/19675668 http://dx.doi.org/10.1371/journal.pone.0006631 |
Ejemplares similares
-
The Evolution of Epigenetic Regulators CTCF and BORIS/CTCFL in Amniotes
por: Hore, Timothy A., et al.
Publicado: (2008) -
Widespread Expression of BORIS/CTCFL in Normal and Cancer Cells
por: Jones, Tania A., et al.
Publicado: (2011) -
Expression of the Epigenetic factor BORIS (CTCFL) in the Human Genome
por: de Necochea-Campion, Rosalia, et al.
Publicado: (2011) -
BORIS/CTCFL is an RNA-binding protein that associates with polysomes
por: Ogunkolade, Babatunji W, et al.
Publicado: (2013) -
Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene
por: Hoivik, Erling A., et al.
Publicado: (2014)